IGF-1 LR3 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
IGF-1 LR3 (Insulin-like Growth Factor-1 Long Arginine 3) is a Growth factor analog, IGF-1 receptor agonist researched for rapid muscle growth, accelerated recovery, bone density increase, tendon healing, neurological protection, localized anabolic effect at injection site. Common dosages range from 20-100 mcg daily; conservative protocols use 20-40 mcg administered once daily, typically post-workout. Below are the most frequently asked questions.
Frequently Asked Questions About IGF-1 LR3
What is IGF-1 LR3?
IGF-1 LR3 (Insulin-like Growth Factor-1 Long Arginine 3) is a Growth factor analog, IGF-1 receptor agonist. Synthetic analog of endogenous IGF-1 with arginine extension and leucine substitution increasing half-life 20-30x over native IGF-1. It is researched for rapid muscle growth, accelerated recovery, bone density increase, tendon healing, neurological protection, localized anabolic effect at injection site.
What is the recommended IGF-1 LR3 dosage?
Common dosages range from 20-100 mcg daily; conservative protocols use 20-40 mcg, administered once daily, typically post-workout via subcutaneous injection (intramuscular for localized effect). Cycles typically run 4-8 weeks maximum to prevent receptor desensitization and insulin resistance.
What are the side effects of IGF-1 LR3?
Hypoglycemia is the most critical risk (shakiness, sweating, confusion, potential loss of consciousness). Insulin resistance with prolonged use. Fluid retention, headaches, joint stiffness, carpal tunnel syndrome. Theoretical cancer risk through mitogenic effects at supraphysiological doses. Acromegalic changes possible with chronic abuse.
Is IGF-1 LR3 legal?
Not FDA-approved. WADA prohibited at all times with no Therapeutic Use Exemption pathway. Classified as research reagent.
What is the half-life of IGF-1 LR3?
The half-life of IGF-1 LR3 is 20-30 hours (vs. ~15 minutes for native IGF-1), which determines the once daily, typically post-workout dosing schedule.
How do you reconstitute IGF-1 LR3?
Add bacteriostatic water to the lyophilized IGF-1 LR3 vial. Let the water run down the side — never spray on the powder. Swirl gently. Use our peptide calculator for exact amounts.
Can you stack IGF-1 LR3 with other peptides?
Pairs with GHRP-2/6 or Hexarelin for synergistic anabolism. Often stacked with insulin post-workout to manage hypoglycemia risk. Requires glucose monitoring and careful food timing.
Where can you buy IGF-1 LR3?
IGF-1 LR3 is available as a research chemical from vetted suppliers with third-party COA testing.
How long does it take IGF-1 LR3 to work?
Initial effects may be noticed within 1-2 weeks, with more significant results typically appearing by weeks 4-8 of a 4-8 weeks maximum to prevent receptor desensitization and insulin resistance cycle.
What makes IGF-1 LR3 unique?
The most potent direct anabolic peptide available with localized growth effects at injection sites — but also the most dangerous in terms of hypoglycemia risk, making it unsuitable for beginners.
Complete Guide
IGF-1 LR3 : Dosing, Mechanisms & Research
Related Reading
- IGF-1 LR3 Dosage Guide
- IGF-1 LR3 Benefits
- IGF-1 LR3 Side Effects
- IGF-1 LR3 Stacking Guide
- IGF-1 LR3 Cycle Guide
- IGF-1 LR3 Research
Calculate Your IGF-1 LR3 Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for IGF-1 LR3.
Open Calculator →Research-Grade Sourcing
If you're going to research IGF-1 LR3, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is IGF-1 LR3?
IGF-1 LR3 (Insulin-like Growth Factor-1 Long Arginine 3) is a Growth factor analog, IGF-1 receptor agonist. Synthetic analog of endogenous IGF-1 with arginine extension and leucine substitution increasing half-life 20-30x over native IGF-1. It is researched for rapid muscle growth, accelerated recovery, bone density increase, tendon healing, neurological protection, localized anabolic effect at injection site.
What is the recommended IGF-1 LR3 dosage?
Common dosages: 20-100 mcg daily; conservative protocols use 20-40 mcg administered once daily, typically post-workout via subcutaneous injection (intramuscular for localized effect). Cycle length: 4-8 weeks maximum to prevent receptor desensitization and insulin resistance. Half-life: 20-30 hours (vs. ~15 minutes for native IGF-1). Use our peptide calculator for exact reconstitution math.
What are the side effects of IGF-1 LR3?
Hypoglycemia is the most critical risk (shakiness, sweating, confusion, potential loss of consciousness). Insulin resistance with prolonged use. Fluid retention, headaches, joint stiffness, carpal tunnel syndrome. Theoretical cancer risk through mitogenic effects at supraphysiological doses. Acromegalic changes possible with chronic abuse.
Is IGF-1 LR3 safe?
IGF-1 LR3 has shown a preliminary safety profile in research. Not FDA-approved. WADA prohibited at all times with no Therapeutic Use Exemption pathway. Classified as research reagent. All research should follow appropriate safety protocols.